Q32 Bio
Clinical-stage biotechnology company developing therapies targeting the complement and cytokine pathways to treat autoimmune, inflammatory, and other serious diseases.
Website
https://www.q32bio.comLocation
Cambridge, Massachusetts, USA
Founded
2018
Investors
1
Categories
biotech, autoimmune, immunology, complement-system
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |